Given the relatively high prevalence of KRAS mutations in the Iranian CRC patients, these findings alert physicians to patients that may be at elevated risk for carrying a tumor with KRAS mutation as the focus for screening. The gene discussed is KRAS; the disease is colorectal carcinoma.